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Abstract
The recent identification of genes implicated in hereditary recurrent fevers has allowed their specific diagnosis. So far
however, only punctual mutations have been identified and a significant number of patients remain with no genetic
confirmation of their disease after routine molecular approaches such as sequencing. The possible involvement of sequence
rearrangements in these patients has only been examined in familial Mediterranean fever and was found to be unlikely. To
assess the existence of larger genetic alterations in 3 other concerned genes, MVK (Mevalonate kinase), NLRP3 (Nod like
receptor family, pyrin domain containing 3) and TNFRSF1A (TNF receptor superfamily 1A), we adapted the qPCR-HRM
method to study possible intragenic deletions and duplications. This single-tube approach, combining both qualitative
(mutations) and quantitative (rearrangement) screening, has proven effective in Lynch syndrome diagnosis. Using this
approach, we studied 113 unselected (prospective group) and 88 selected (retrospective group) patients and identified no
intragenic rearrangements in the 3 genes. Only qualitative alterations were found with a sensitivity similar to that obtained
using classical molecular techniques for screening punctual mutations. Our results support that deleterious copy number
alterations in MVK, NLRP3 and TNFRSF1A are rare or absent from the mutational spectrum of hereditary recurrent fevers, and
demonstrate that a routine combined method such as qPCR-HRM provides no further help in genetic diagnosis. However,
quantitative approaches such as qPCR or SQF-PCR did prove to be quick and effective and could still be useful after non
contributory punctual mutation screening in the presence of clinically evocative signs.
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Introduction
The hereditary recurrent fever syndromes are a group of auto-
inflammatory disorders characterized by self-limited episodes of
fever accompanied by inflammation of the serosal membranes,
without apparent infectious etiology [1]. Included in this group are
familial Mediterranean fever (FMF) and mevalonate kinase
deficiencies (MKD; MIM#610377 for mevalonic aciduria and
260920 for hyper-IgD syndrome), all of which are recessively
inherited. Dominantly inherited syndromes have also been
described, such as TNF receptor associated periodic syndrome
(TRAPS; MIM# 142680) and cryopyrin associated periodic
syndromes (CAPS; MIM#120100 for familial cold autoinflam-
matory syndrome 1, 191900 for Muckle-Wells syndrome and
607115 for CINCA syndrome) [2].
The vast majority (FMF 97%; CAPS 96%; TRAPS 95%; MKD
81%) of the mutations implicated in the hereditary recurrent fever
syndromes are punctual substitutions, and have been recorded in
the dedicated online database INFEVERS (http://fmf.igh.cnrs.fr/
ISSAID/infevers/). However, most laboratories use molecular
techniques such as sequence analysis or exon screening (DGGE,
Denaturing Gradient Gel Electrophoresis, dHLPC, denaturing
high performance chromatography, HRM, High Resolution
Melting analysis) that only allow for the identification of micro-
rearrangements. On the other hand, a significant number of
apparently mutation-free patients show evocative symptoms of
hereditary recurrent fevers. The possible involvement of sequence
rearrangements in these diseases has only been examined in FMF
and was found to be unlikely [3]. Several methodological
approaches have been have been described to search for such
gene alterations: SQF-PCR, semi-quantitative fluorescent PCR
[4]; MLPAH, multiplex ligation-dependent probe amplification
[5]; MAPH, multiplex amplification probe hybridization [5];
qPCR, quantitative PCR [6]. More recently, innovative ap-
proaches have been developed that allow the simultaneous, rapid
and accurate detection of both micro and macro-rearrangements
in genes responsible for hereditary cancers. This strategy, called
qPCR-HRM, is based on a real time PCR assay (gene dosage
quantitative analysis) combined with HRM curves (qualitative
analysis of punctual mutations) in a single tube [7].
To search for sequence rearrangements in our patients, we
adapted the qPCR-HRM method for the study of intragenic
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MIM#251170; NM_000431.1), NLRP3 (Nod like receptor family,
pyrin domain containing 3, MIM#606416; NM_004895.3) and
TNFRSF1A (TNF receptor superfamily 1A, MIM#191190;
NM_001065.2) genes, responsible for MKD, CAPS and TRAPS
respectively. We used SQF-PCR as a confirmatory approach.
Materials and Methods
Study group
The study includes a total of 201 patients referred for the genetic
diagnosis of hereditary recurrent fevers in our reference laboratory
specialized in auto-inflammatory disorders (Montpellier, France).
Informed consent was obtained from all participating subjects.
The study design consisted in the delineation of two groups of
patients (summarized in Figure 1). The prospective study included
patients unselectively recruited over a period of 6 months in 2009
(N=113). The retrospective study included 88 selected patients
previously genotyped using our routine diagnosis strategy
(screening by sequencing and/or DGGE of hot spot mutations,
i.e. MVK, all exons; NLRP3: exon 3). The selection criteria for
MKD (N=12) was the detection of only a single mutation and for
CAPS (N=76), it was evocative signs, i.e. recurrent fever,
urticaria, arthralgia and sometimes neurosensorial deficiency. No
TRAPS patients were retrospectively selected since the clinical
spectrum for this disease is too unspecific.
DNA extraction
Human genomic DNA was prepared from whole-blood samples
using the QIAmp DNA blood kit (Qiagen, Courtaboeuf, France)
according to the manufacturer’s standard protocol. The quality
and concentration of the DNA was assessed using a NanodropH
spectrophotometer (Coleman Technologies, Orlando, FL). DNA
working solutions were prepared at a concentration of 5ng/ul for
qPCR-HRM and qPCR, and 50ng/ul for SQF-PCR.
qPCR-HRM and qPCR
Primer design. Common primers were used for qPCR-
HRM and qPCR for the screening of exons containing mutation
hot spots. Specific primers were designed for the other exons
(retrospective study). Since effective primer design is an important
component of HRM analysis, all amplicons were chosen to
contain a single melting domain as assessed using the Poland pro-
gram (http://www.biophys.uni-duesseldorf.de/local/POLAND/
poland.html [8]. The PrimerBlast software (NCBI, http://www.
ncbi.nlm.nih.gov/tools/primer-blast/, date of access 03/20/2010)
was used to design primers with the same melting temperature
(60uC), and to result in amplicons ranging between 100 and
400 bp in size. All primer sequences used in this work are listed in
Table 1. The primer pairs were validated if they matched the
following conditions: PCR efficiency range between 80–100% as
determined using a DNA concentration gradient (40ng-20ng-
10ng-5ng-2.5ng), Cycle threshold (Ct) lower than 30 cycles, and all
pathological genotypes detected in the validation set.
Assay conditions
qPCR-HRM and qPCR were performed in a single run using a
LightCycler 480 instrument (Roche diagnostics, Meylan, France).
Reaction mixtures contained 10 ng genomic DNA, 0.25mMo f
each primer, 3mM MgCl2 and 16 LightCycler 480 High
Figure 1. Flow chart for the screening of mutations in the genes MVK, NLRP3 and TNFRSF1A. In our patient cohort, we performed a
simultaneous search for punctual mutations and gene rearrangements using qPCR-HRM in the prospective group and qPCR alone in the
retrospective group (as these patients had already been assessed for qualitative alterations), then SQF-PCR in both groups as a confirmatory
quantitative approach.
doi:10.1371/journal.pone.0014096.g001
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Gene/Exon Forward Primer Reverse Primer Amplicon size (bp) Multiplex set
qPCR-HRM
1
B2M/2 cactgaaaaagatgagtatgcc Aacattccctgacaatccc 231
DMD/16 tctatgcaaatgagcaaatacacgc ggtatcactaacctgtgctgtactc 290
MVK/2 tcttcctgctggttctgaca gcatcagggagaaggggta 203
MVK/3 tcaccctcaggcttattgct tggtttctcctccttgcact 210
MVK/4 ccctctcacccacttgtgtt aggctgaatctggactccttc 226
MVK/5 cgggagagtcacgtttcac gacactggccaggtaaggac 221
MVK/6 ccactcctcactgccacag ctcttgggcacctaccattg 221
MVK/7 cctctctcccaagtagcacag ccctgcacacatcaatgc 170
MVK/8 tgagttcagtgtggacctgc taattgtgtcctggccttcc 181
MVK/9
2 gaacacctcctccctccac ttctgagcacagccagattg 295
MVK/10 aagtgggaacagatggaacct ccaatgaggaagcaaagacc 346
MVK/11 gtcaagggtgacctgccttc gcctctccagcagtgtcag 300
NLRP3/3a gatgtgtgtatactttccccctaa aaacctgtcttggtagagtgtcc 399
NLRP3/3c agcctcatcagaaagaagctg tgaggtcggactcctcaaac 469
NLRP3/3d tctttggctgcagatggaat ttgctgagagatcttgcaactta 399
NLRP3/3e tttcctctttggcctggtaa agaagaagctggcgaggaag 477
NLRP3/3c
3 gcctctctgctcatcacgac gctcttgccactctccatct 264
TNFRSF1A/2 ttgatggtgtctcctctatctga aagaagcagcaccccagac 240
TNFRSF1A/3 gggctccttccttgtgttct cacatagacaggcacccaca 247
TNFRSF1A/4 agaaatgggtcaggtggagat gccagagaggagttggttgt 280
qPCR
MVK/9
2 accagccgttccttcttttt ttctgagcacagccagattg 230
NLRP3/2 ggggtctcctctctcatgc ctagaagcaccaccccagtc 242
NLRP3/4 tcgaggctgatttcttttctg gcactcacacagatcacatgc 248
NLRP3/5 tctgatgctttctgcctctgt cgctggcagaacttccttag 244
NLRP3/6 tgactgacattctgccatctct tctggtaagacacccatgaaga 227
NLRP3/7 ggaacagctgggtactgagg cttgtggccactctgccta 295
NLRP3/8 aatcaccccctttttgcag agagccatcctggattttga 274
NLRP3/9a agtgcaacccaggctttcta tcacagagctgtggtcttgg 240
SQF-PCR
4
GFAP/3 gaggaaaggattgatggcca gaggaggagatccggttctt 249 Control (A to H)
DMD/28 tgcattttgaattacctgctaca agtaccaaatagaagacaaatccaaag 361 Control (A to H)
MVK/2 tattatgatgggcttgaactagg tgcctcagggtgtcctttta 292 A
MVK/3 cttcttagcacgtgggtcct ctctctgtaggctctt 286 A
MVK/4 gtcgattttctgtgttctgttgtt agagcatgtgcattctccag 337 B
MVK/5 ctggaccagatgcttggagt aagccacgtccctgtcctg 336 A
MVK/6 gagtggacttgttctttctgagc agactcttgggcacctacca 328 B
MVK/7 ttcctgaatggggcaaaat ctgcctcctatggtacttccc 266 C
MVK/8 gtatcagggtgggcggcttcc gagggagacctcgaaaatcc 279 A
MVK/9 ggctgtgtgaacacctcctc cacagccagattgcagagcca 314 B
MVK/10 tctccagccaacaactgtca tcaagggaattctccaggtg 348 C
MVK/11 ctgggcttttgccttgaat aataatccagaaaggggcatc 304 C
TNFRSF1A/1 accaggccgtgatctctatg cactcttccctttgtccctg 224 H
TNFRSF1A/2 aggacttgagccagggaagt tttccttggggacacacact 198 D
TNFRSF1A/3 ctggctgttgtccctagcat cacccacacaccactcaaga 256 E
TNFRSF1A/4 agaaatgggtcaggtggagat ttggttgtcagacccacaga 268 D
TNFRSF1A/5 acaaccaacttcctctctggc atctgttgcccagctaatgg 277 I
TNFRSF1A/6 caccagtgccgtctcttctt atagatggatgggtgggatg 186 I
TNFRSF1A/7 aacacctgctttgtctgcag accttctgcccagagtccc 268 H
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France) containing Taq polymerase, nucleotides and the dye
Resolight in a total volume of 10ml. We used the same cycling
conditions for all reactions: an activation step at 95uC for 10 min
followed by 50 cycles of 95uC for 15s, a touchdown from 65 to
55uC for 15s (0.5uC/cycle) and 72uC for 20s. Following
amplification, products were heated to 95uC for 1 min and cooled
to 40uC for 1 min to favor heteroduplex formation. For the
melting step, the temperature was raised from 75uCt o9 7 uC with a
ramp rate of 0.02uC/s and 25 acquisitions/uC. All reactions were
performed at least twice. Each experiment included male or
female wild-type DNA (for quantitative calibration and as a
qualitative negative control), and positive control DNA with a
known point mutation (as a qualitative positive control). All
controls are summarized in Table 2.
Qualitative analysis for punctual mutation screening
Upon completion of the run of the qPCR-HRM (approximately
2 hours), HRM curve analysis was performed using the Light-
Cycler 480 Software version 1.5 supplied with the device. The
melting curves were normalized and temperature shifted to allow
the direct comparison of samples. Difference plots were generated
by selecting a negative control, converting the melting profile to a
horizontal line and normalizing the melting profiles of the other
samples against the test sample. Significant differences in
fluorescence from the horizontal baseline were indicative of
mutations. Differences were judged as significant if the replicates
fell outside the range of variation seen in the wild type samples.
Quantitative analysis for sequence rearrangement
screening
Standard curves were generated for all exons investigated
(Figure 1) and for two reference genes (exon 16 of the X-linked
gene DMD, and exon 2 of B2M) to derive sample and calibrator
(negative control) relative DNA amounts. The ratio (R) represent-
ing the relative copy number of the target exon in the patient was
automatically calculated by the LightCycler 480 data analysis
software (LC480; Roche) according to the formula:
R~
target exon concentration=reference exon concentration ½  patient
target exon concentration=reference exon concentration ½  control
The gene DMD was analyzed in each experiment as a control of
correct gene dosage: the ratio DMD/B2M should be equal to two
for female samples, and one for male samples.
SQF-PCR
Primer design. The method of SQF-PCR is based on the
comparison of fluorescent profiles of multiplex PCR fragments
obtained from different samples (patients and control)
4. Primers
labeled with 6FAM fluorochrome (Table 1) for exons 2–10 of
MVK, exons 1–10 of TNFRSFA1, exons 1–9 of NLRP3, and 2
internal control genes (exon 28 of DMD and exon 3 of GFAP) were
designed using the PrimerBlast software (http://www.ncbi.nlm.
nih.gov/tools/primer-blast/). We chose allele pairs with the same
annealing temperature to perform multiplex PCR resulting in
fragments of sizes differing by at least 20bp (186–361 bp). We
checked that all exons were adequately co-amplified.
Assay conditions
The PCR reactions were performed using the QIAGEN
Multiplex kit (Qiagen, Courtaboeuf, France) in a total volume of
20 ul containing 100 ng of genomic DNA and 5 to 20 pMol of
each primer. The amplification was stopped at the exponential
phase (22 cycles). The PCR cycling conditions used were those
suggested in the manufacturer’s instructions. The PCR products
were then separated on an ABI3130xL DNA Sequencer (Applied
Biosystems, Foster city, CA, USA).
Semi-quantitative analysis
Electrophoregrams were analyzed using the GeneMapper
software v4.0 (Applied Biosystems, Foster City, CA, USA). In
each experiment, the genes GFAP and DMD were analyzed to
determine the relative gene dosage for MVK, NLRP3 and
TNFRSFA1. To calculate the relative copy number (R) of each
target region, each peak value including height and area from the
patient samples was compared with those from the normal control
Gene/Exon Forward Primer Reverse Primer Amplicon size (bp) Multiplex set
TNFRSF1A/8–9 gggaaatcgacacctgaaaa aagctccccctgaaagagag 233 H
TNFRSF1A/9–10 cccttcagaagtgggaggac gatcgatctcgtggtcgct 305 I
NLRP3/1 ccagagccttcagtttggag aggagtgtgtcctgagccat 269 G
NLRP3/2 ccactgtgatatgccaggaa gcattccaaagagcaggaac 208 F
NLRP3/3 gcatctcaggtggatgtgtg caggctcagaatgctcatca 307 G
NLRP3/4 cctcacttccagtttttgcc gcactcacacagatcacatgc 189 G
NLRP3/5 tctgtgtgtgggactgaagc ctttccccacgacaaacact 228 F
NLRP3/6 tcagtattgagcaccagcca tgaccaaagtaacccccatc 213 G
NLRP3/7 gagtcaaagcagctgcacaa ccaccatgtgttctcattgc 283 F
NLRP3/8 gggatggttaaggggacatt caggcccaacctaatcttga 339 G
NLRP3/9a tgcaacccaggctttctatt tgctgtcattgtcctggtgt 348 F
1All primers (except HRM-qPCR MVK/9 primer) showed a PCR efficiency range between 80 and 100% (IC+/20.2%).
2qPCR and HRM of MVK exon 9 could not be performed in the same run due to low PCR efficiency. We used therefore two different primer pairs.
3p.T348M allele specific primer.
4Forward primers were 6FAM labeled. Nine distinct PCR sets (Multiplex A to I) were designed, each yielding a pattern of 3 to 6 peaks including the 2 control fragments
(DMD and GFAP).
doi:10.1371/journal.pone.0014096.t001
Table 1. Cont.
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and height of peak) were exported to Microsoft Excel and inserted
into the equation:
R~
target exon height or peak area=reference exon height or peak area ½  patient
target exon height or peak area=reference exon height or peak area ½  control
The DMD gene was used as a control of correct gene dosage: the
ratio (R) DMD/B2M should be equal to two for female samples
and one for male samples.
Results
We first implemented qPCR-HRM as a valid method for
screening hereditary recurrent fever genes in our laboratory. Then
in our patient cohort, we conducted a simultaneous search for
punctual mutations and gene rearrangements using qPCR-HRM
in the prospective group and qPCR alone in the retrospective
group (as these patients had already been assessed for qualitative
alterations), then SQF-PCR in both groups as a confirmatory
quantitative approach (Figure 1).
Validation of qPCR-HRM
To implement a strategy that could be used on a routine basis,
we set the method up to focus on mutation hot spots (MVK, exons
2–11; NLRP3, exon 3; TNFRSF1A, exons 2–4). The qPCR-HRM
method could be performed for all regions except MVK exon 9 for
which the Ct could not be obtained below 30 cycles. For this exon,
we therefore conducted separate HRM and qPCR. The validation
process included a number of DNA controls to assess the successful
detection of a variety of gene alterations.
To validate the mutation analysis (HRM), we used 49 DNA
samples carrying known mutations and 48 wild-type controls
(Table 2). The sensitivity of the technique in our conditions
(93.8%) was comparable to other mutation screening methods [9].
Indeed, all pathological mutations (homozygous or heterozygous)
were detected, and only 3 polymorphisms (c.769-7_769-6dupT in
MVK and p.A242A, p.Y141Y in NLRP3) went undetected (not
shown).
To validate the gene dosage (qPCR), we used DNA samples
from 3 individuals (Table 2): 1) One patient with no recurrent
fever in whom was found a large deletion (2,13Mb,
Chr12:107813096..109948089, version: NCBI36/hg18) including
the MVK gene in an unrelated study (micro-array screening for
mental retardation); 2) One patient with a p.T348M (c.1043C.T)
mutation in NLRP3 in whom we performed allele specific PCR
using a wild-type primer to mimic a deletion; 3) One patient with 3
copies of the gene ITGB5 (154.9kb, Chr3:125946672..126101558,
version NCBI36/hg18), since we had no available sample with a
duplication in our genes of interest. As normal controls, 10 DNA
samples from asymptomatic individuals were screened. Expected
copy numbers were obtained (Figure 2).
Prospective study: qPCR-HRM has little relevance for
routine genetic diagnosis of hereditary recurrent fevers. To
Table 2. Controls used in this work.
qPCR-HRM SQF-PCR
HRM (Qualitative) qPCR (Quantitative) (Semi-Quantitative)
Validation Set
Negative Controls N=48 Wild-type DNAs N=10 Asymptomatic individual N=10 Asymptomatic
individual
Positive Controls N=49 DNAs with known punctual mutations: N=3 DNAs with or mimicking a CNV{: N=1 DNA with a deletion
MVK (N=19) p.S52N
(1)(2),c.371+8C.T
(1)(2),
p.S135L
(1), p.S135S
(1),
p.D170D
(1)(2),c.632218A.G
(1)(2),
c.769-7_769-
6dupT
(1)*,c.885+24G.A
(1)(2),
p.G309S
(1), p.S329N
(1), p.V377I
(1)(2),
p.R388X
(1), p.E296GfsX14
(1)
MVK (N=1) Chr12q24.1del MVK
(N=1)
Chr12q24.1
del
NLRP3 (N=23) c.278245T.C
(1), p.Y141Y
(1)*,
p.R168Q
(3), p.V198M
(1), p.T219T
(1),
p.A242A
(1)(2)*, p.P340P
(1)(3),
p.L344L
(1)(3), p.A439P
(1), p.H463H
(1),
p.T587I
(1), p.Q703K
(1)(2),
p.Y859C
(1),c.3005+25C.T
(1),
p.T348M
(1), p.L411L
(3), p.S434S
(1)(2),
p.T436P
(3)
NLRP3 (N=1) p.T348M artificial
deletion (allele
specific primer)
TNFRSF1A (N=7) p.C30R
(1), p.C30F
(1), p.C73W
(1),
p.H69fs
(1), p.E54E
(1), p.P46L
(1),
p.R92Q
(1)
ITGB5 (N=1) Chr3q21.2dup
Study group
Negative Controls N=1 Wild-type DNA N=1 Asymptomatic individual N=1 Asymptomatic indivi-
dual
Positive Controls N=1 DNA with a known variation per exon tested where
available
N=1 DMD (Internal control) N=1 DMD (Internal
control)
(1) heterozogote,
(2) homozygote,
(3) compound heterozygote.
*These polymorphisms were not detected by HRM.
{Copy number variation.
doi:10.1371/journal.pone.0014096.t002
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we applied it to our prospective study group consisting of 113
unselected patients referred for genetic diagnosis. All amplicons were
sequenced in parallel. We confirmed diagnosis in 6 patients, all of
whom bore already known mutations: three associated with MKD,
p.[V377I]+[V377I], p.[V377I]+[G226S], and p.[T237S]+[T237S];
one with CAPS, p.T348M; and two with TRAPS, p.C70R and
p.R92Q. Representative HRM difference plots are shown in
Figure 3. The qualitative step (melting curves) detected all the
mutations except the T237S homozygous genotype which was only
detected after equimolar mixing with a wild type sample using the
HRM method alone (not shown). The quantitative step detected no
gene dosage abnormalities (Figure 2). A second method (SQF-PCR)
was performed on a subset of these patients and confirmed the
absence of copy number variants in this cohort (Figure 4).
Retrospective study: sequence rearrangements are likely
absent in hereditary recurrent fever genes. To confirm this
absence of copy number alterations in our genes of interest and
enhance the probability of finding new mutations, we extended
our series to a panel of selected patients with recurrent fever
(N=88, Figure 1) with either one MVK punctual mutation for
MKD, or urticaria and/or neurosensorial symptoms for CAPS.
Indeed, FMF had previously been addressed
3 and TRAPS does
not show a clear cut phenotype. In this retrospective series,
punctual mutations in all coding exons and intron boundaries had
already been investigated using classical one-step routine analysis
(HRM and/or sequencing). No genetic rearrangements were
identified (Figure 2). We also performed a second SQF-PCR
method in this retrospective panel which confirmed the absence of
intragenic duplications or deletions (Figure 4).
Discussion
The existence of a significant number of patients with convincing
symptoms though not carrying point mutations suggests that other
genes and/or mutational mechanisms, such as gene dosage
alteration, could be involved in the etiology of hereditary recurrent
fever syndromes. The aim of this study was therefore to explore the
possible existence of copy number variants in hereditary recurrent
fever genes and estimate the usefulness of qPCR-HRM in routine
diagnosis. Duplications and deletions of the genes involved in
MKD, a recessive enzymopathy [10], and TRAPS, thought to be a
protein misfolding disorder could theoretically lead to these two
diseases [11]. CAPS is due to gain-of-function mutations in NLRP3,
a major protein of the inflammasome platform that activates pro-
caspase-1 into its active form caspase 1, which in turn promotes the
processing of the potent pro-inflammatory cytokine interleukin-1b
[12]. Classical gain-of-function rearrangements (e.g. duplications)
have never been recorded in CAPS. However, a nonsense mutation
(p.Arg554X) was identified in NLRP3 putatively resulting in a
Figure 2. Results of MVK, NLRP3 and TNFRSF1A gene dosage analysis by qPCR-HRM (prospective study) and qPCR (retrospective
study). We screened by qPCR-HRM (i) exons 2–8 and 10–11 of the MVK gene in 10 controls, 1 DNA sample with a 12q23.2 deletion, and 49 patients,
(ii) the exon 3 of the NLRP3 gene in 9 controls, 10 patients, and the artificial positive p.T348M patient and (iii) exons 2–4 of the TNFRSF1A gene in 13
controls and 54 patients. We screened by qPCR (i) exon 9 of the MVK gene in 10 controls, 1 DNA sample with a 12q23.2q24.11 deletion, and 12
patients and (ii) exons 2–9 of the NLRP3 gene in 9 controls and 38 patients.
R~
target exon concentration=reference exon concentration ½  patient
target exon concentration=reference exon concentration ½  control
The red bars indicate the range limits of the control ratios, between 0.75 and 1.28.
doi:10.1371/journal.pone.0014096.g002
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deleted protein could therefore result in a gain-of-function.
To address the issue of possible pathological copy number
variations in hereditary recurrent fevers, we took advantage of the
fact that the HRM mutation screening technique is already
routinely used in our laboratories, and implemented a recently
described strategy that combines point mutation and gene
rearrangement detection in a single assay (qPCR-HRM). This
approach proved useful for the genetic analysis of MLH1 in Lynch
syndrome [7]. The main advantage of qPCR-HRM is the gain in
terms of cost and time. Another major benefit is the validation of
amplification of the two alleles through the quantitative measure,
which avoids the misinterpretation of primer mismatch of one
allele as a deletion, and validates homozygous genotypes. We
found the sensitivity of qPCR-HRM for qualitative analysis as
compared to sequencing (93.8%) to be similar to that of classical
qualitative methods such as DGGE or dHPLC [9]. The sensitivity
of qPCR-HRM and SQF-PCR for quantitative analysis was
100% for the positive controls. The known limit of qPCR-HRM
is the difficulty in designing primers efficient for both qualitative
Figure 3. Pathological genotypes detected by qPCR-HRM in the prospective study. Qualitative changes were assessed using the gene
scanning module of the LightCycler 480 Software version 1.5. Wild type sequences were used to define baselines. Difference plots revealed disease
associated variants.
doi:10.1371/journal.pone.0014096.g003
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PLoS ONE | www.plosone.org 7 November 2010 | Volume 5 | Issue 11 | e14096detection and quantitative dosage. Among the 21 amplicons we
designed, only exon 9 of MVK could not be assessed by qPCR-
HRM.
Having validated this new method being in our laboratories, we
then used it to assess our patients in a prospective and
retrospective study. We detected no gene dosage alteration in a
total of 159 patients suspected of MKD, CAPS or TRAPS. A
previous study in patients with FMF using MLPA also found no
genetic rearrangements. A recent review demonstrated that copy
number variants are more frequent in large genes [14]. The
hereditary recurrent genes are in contrast rather small (MVK:
23434bp, NLRP3: 31054bp, TNFRSF1A: 13231bp). To investigate
whether the chromosomal regions containing these genes could
contain fragile sites, we consulted the Database of Genomics
Variants (http://projects.tcag.ca/variation) and the Copy Number
Variation project at the Children’s Hospital of Philadelphia
(htpp://cnv.chop.edu). We retrieved no copy variant within the
regions of the MVK and TNFRSF1A genes. However, 3 variants
have been reported in apparently healthy individuals in the 1q44
region of NLRP3, the largest of the 3 genes: 1) an insertion of
147bp in intron 3 of the NLRP3 gene (position 245657612 on
chromosome 1q, version NCBI36/hg18) in one Caucasian
individual [15]; 2) a deletion spanning intron 4 to the 59extremity
of exon 5 (chr1:245663794..245664071) in one Asian individual
[16]; and 3) complex rearrangements upstream of the NLRP3 gene
in 50 French individuals [17]. This may indicate the localization of
NLRP3 in or close to a minor fragile site, although we identified no
pathological rearrangements in our series.
In conclusion, our previous and present results support that
deleterious intragenic rearrangements in MEFV, MVK, NLRP3 and
TNFRSF1A are rare or absent from the mutational spectrum of
hereditary recurrent fevers, suggesting that other mutations in
seemingly affected patients should be searched for either in other
gene regions (e.g. promoter and introns) or in other candidate
genes. The use of the combined qPCR-HRM as a first line
approach for genetic diagnosis is not relevant for these diseases
since only qualitative alterations were identified. However, rare
pathological gene dosage alterations could still be found in future
series and the method we have developed could be used punctually
as a second approach since it proved effective and quick.
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Figure 4. Results of MVK, NLRP3 and TNFRSF1A gene dosage analysis by SQF-PCR. We screened by SQF-PCR (i) all coding exons of the MVK
gene in 9 controls, 1 DNA sample with a 12q23.2 deletion, and 28 patients (ii) all coding exons of the NLRP3 gene in 9 controls and 86 patients and (iii)
all coding exons of the TNFRSF1A gene in 9 controls and 54 patients.
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The red bars indicate the range limits of the control ratios, between 0.75 and 1.25.
doi:10.1371/journal.pone.0014096.g004
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